Monopar Therapeutics Inc. (MNPR)

NASDAQ: MNPR · Real-Time Price · USD

57.86

+0.98 (1.72%)

At close: Feb 6, 2026, 4:00 PM EST

56.00

-1.86 (-3.21%)

After-hours: Feb 6, 2026, 6:26 PM EST

Monopar Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 6, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	386	134	5	31	40	70
Market Cap Growth	60.94%	2552.79%	-83.48%	-24.23%	-42.34%	-59.48%
Enterprise Value	242	128	-3	16	18	52
Last Close Price	57.75	22.00	1.70	11.85	16.05	30.60
PB Ratio	2.72	2.44	0.91	3.04	2.13	4.47
P/TBV Ratio	2.73	2.44	0.91	3.04	2.13	4.47
Debt / Equity Ratio	0.00	-	-	0.00	-	-
Quick Ratio	55.94	11.46	4.14	4.19	12.85	14.22
Current Ratio	56.10	11.48	4.17	4.21	12.98	14.28
Return on Equity (ROE)	-26.54%	-51.42%	-107.19%	-72.45%	-52.57%	-44.52%
Return on Assets (ROA)	-17.99%	-29.87%	-53.66%	-39.03%	-30.51%	-26.92%
Return on Capital Employed (ROCE)	-15.30%	-29.40%	-158.00%	-104.30%	-48.20%	-41.50%
Earnings Yield	-5.04%	-11.62%	-166.13%	-34.34%	-22.52%	-9.00%
Buyback Yield / Dilution	-97.28%	-37.09%	-8.70%	-1.97%	-13.82%	-17.56%

Updated Nov 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q